Gastric Acid Secretion

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

2017-18 AGA GI Resource Catalog

May 30, 2017

Whether it’s the latest in clinical education, cutting-edge science or navigating the future of medicine, AGA has you covered. Find resources to address all of your professional needs in the GI Resource Catalog.

DDSEP 8 - Complete

April 12, 2016

The eighth edition of AGA's premier GI education program features new and expanded content to help you enhance your knowledge, build expertise and improve patient care.

Report: New Acid Blocker Holds its Own Against PPIs

Aug. 4, 2015

The study suggests that the novel drug has a similar safety profile as PPIs, which are widely used in treating peptic ulcer recurrence.

AGA DHRP Now Open to Report on Hepatitis C and IBD Data

Oct. 17, 2013

The AGA Digestive Health Recognition Program™ (DHRP) is now open to report on 2013 hepatitis C and IBD data. The DHRP was developed by AGA to make it easy for clinicians to demonstrate quality, achieve recognition, qualify for payor incentives, avoid CMS penalties and earn ABIM MOC points.

NPs, PAs Can Benefit from Popular Course Designed to Address their Unique Needs

March 28, 2013

Hear from the experts as they provide you with the information necessary to treat patients in a variety of practice settings. Receive in-depth instruction on many GI topics, including eosinophilic esophagitis, GERD, small bowel dysmotility and more.

Deadline Extended for Castell Esophageal Clinical Research Award

Jan. 24, 2013

The application deadline for the June & Donald O. Castell, MD Esophageal Clinical Research Award, available through the AGA Research Foundation, has been extended to Feb. 3. Junior investigators who are interested in esophageal disease research are invited to apply.

Post-Menopausal Women Taking Indigestion Drugs at Increased Risk of Fracture

Feb. 9, 2012

The FDA stresses the importance of evaluating the need for long-term use of PPIs among those with a history of smoking.

News You Can Use

Jan. 26, 2012

Is there hope for Crohn's patients who want to stop taking infliximab? Learn more on this and other news you can use via AGA's Twitter page.

Ventana Wins Clearance for H. Pylori Antibody

Oct. 8, 2011

Roche's Ventana unit has garnered 510(k) clearance for its anti-Helicobacter pylori (H. pylori) rabbit monoclonal primary antibody. It is the first H. pylori antibody to receive FDA clearance, and, when used in immunohistochemical staining, helps detect the bacterium.

Fracture Risk with Short-Term, Low-Dose PPIs Unlikely

April 1, 2011

The available data show that patients at highest risk for fractures received high doses of prescription PPIs (higher than over-the-counter PPI doses) and/or used a PPI for one year or more.

H. Pylori Eradication with a Capsule

March 14, 2011

Quadruple therapy should be considered for first-line treatment in view of the rising prevalence of clarithromycin-resistant Helicobacter pylori.

PPIs Are Associated with Hip Fractures

Feb. 14, 2011

Doctors concluded that the duration of exposure to a PPI is associated with an increased likelihood of hip fracture.

TFF2 mRNA Transcript Expression Marks a Gland Progenitor Cell of the Gastric Oxyntic Mucosa

Dec. 3, 2010